Search

Search Constraints

You searched for: Author/Creator Subbiah, Vivek

Search Results

71. Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma. Issue 1 (18th September 2019)

72. Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1/2 study. Issue 8 (August 2021)

73. Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study. Issue 7 (July 2021)

75. Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials. (September 2020)

76. Quantification of the Effect of Shuttling on Computed Tomography Perfusion Parameters by Investigation of Aortic Inputs on Different Table Positions From Shuttle-Mode Scans of Lung and Liver Tumors. Issue 3 (May 2018)

77. Radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers. Issue 4 (13th April 2021)

80. Responsiveness to immune checkpoint inhibitors versus other systemic therapies in RET-aberrant malignancies. Issue 5 (23rd October 2020)